Trial intelligence / Profile preview

Ciprofol versus propofol for perioperative anesthesia in breast cancer surgery after neoadjuvant chemotherapy

ChiCTR2600132480Phase 4Recruiting

Sponsor
Affiliated Cancer Hospital of Shantou University Medical College
Start
May 2026
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ciprofol and propofol in breast cancer (2 arms), sponsored by Affiliated Cancer Hospital of Shantou University Medical College. Primary endpoints: Time of endotracheal tube extubation, Anesthesia induction success rate and 6 more. Started May 2026; status: recruiting.

02

Drugs

ciprofolpropofol
03

Conditions

breast cancer

Beyond the preview

Go deeper on ChiCTR2600132480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600132480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call